- Home
- CYTK vs ACA Comparison
CYTK vs ACA Comparison
Compare CYTK & ACA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- ACA
- Stock Information
- Founded
- CYTK 1997
- ACA 2018
- Country
- CYTK United States
- ACA United States
- Employees
- CYTK N/A
- ACA N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- ACA Metal Fabrications
- Sector
- CYTK Health Care
- ACA Industrials
- Exchange
- CYTK Nasdaq
- ACA Nasdaq
- Market Cap
- CYTK 5.7B
- ACA 4.8B
- IPO Year
- CYTK 2004
- ACA N/A
- Fundamental
- Price
- CYTK $45.82
- ACA $100.81
- Analyst Decision
- CYTK Buy
- ACA Strong Buy
- Analyst Count
- CYTK 15
- ACA 4
- Target Price
- CYTK $83.64
- ACA $105.50
- AVG Volume (30 Days)
- CYTK 1.1M
- ACA 231.0K
- Earning Date
- CYTK 02-25-2025
- ACA 02-20-2025
- Dividend Yield
- CYTK N/A
- ACA 0.20%
- EPS Growth
- CYTK N/A
- ACA N/A
- EPS
- CYTK N/A
- ACA 2.63
- Revenue
- CYTK $3,219,000.00
- ACA $2,485,900,000.00
- Revenue This Year
- CYTK N/A
- ACA $13.83
- Revenue Next Year
- CYTK $710.83
- ACA $13.89
- P/E Ratio
- CYTK N/A
- ACA $38.25
- Revenue Growth
- CYTK N/A
- ACA 11.68
- 52 Week Low
- CYTK $44.49
- ACA $72.75
- 52 Week High
- CYTK $84.92
- ACA $113.43
- Technical
- Relative Strength Index (RSI)
- CYTK 39.27
- ACA 54.51
- Support Level
- CYTK $44.49
- ACA $96.48
- Resistance Level
- CYTK $48.45
- ACA $98.92
- Average True Range (ATR)
- CYTK 1.65
- ACA 2.22
- MACD
- CYTK -0.08
- ACA 0.56
- Stochastic Oscillator
- CYTK 23.50
- ACA 91.60
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About ACA Arcosa Inc.
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.